Portal de Periódicos da CAPES

Excitatory Amino Acid Agonist‐Antagonist Interactions at 2‐Amino‐4‐Phosphonobutyric Acid‐Sensitive Quisqualate Receptors Coupled to Phosphoinositide Hydrolysis in Slices of Rat Hippocampus

1988; Wiley; Volume: 50; Issue: 5 Linguagem: Inglês

10.1111/j.1471-4159.1988.tb03050.x

1471-4159

Darryle D. Schoepp, Bryan G. Johnson,

Ion channel regulation and function

Abstract: Studies were carried out to define the relative affinities and intrinsic activities of excitatory amino acid agonists that activate receptor sites coupled to phosphoinositide hydrolysis in brain. Slices of rat hippocampus were prelabeled with myo ‐[ 3 H]inositol, and agonist stimulation was indexed by measuring the accumulation of [ 3 H]inositol monophosphate ([ 3 H]IP) in the presence of Li + . It was observed that ibotenic (IBO) and quisqualic (QUIS) acids both elicit highly significant, concentration‐dependent stimulation of phosphoinositide hydrolysis. Whereas maximal stimulation by IBO (10 −3 M ) was four‐ to fivefold over basal values, the maximal effect of QUIS (10 −4 M ) was less (about twofold). Based on the relative concentrations required for 50% maximal stimulation, QUIS was 20 times more potent than IBO. Stimulation of phosphoinositide hydrolysis by either IBO or QUIS was additive to the effects of nonexcitatory amino acid agonists (carbachol and norepinephrine) in this tissue. However, the stimulatory effects of IBO plus QUIS were not additive. At ≥ 10 −4 M , QUIS significantly inhibited phosphoinositide hydrolysis by a maximal stimulatory concentration of IBO (10 −3 M ) to a level observed with QUIS alone. Other excitatory amino acid agonists, including kainate, N ‐methyl‐d‐aspartate, and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA), had no stimulatory effects at concentrations as high as 10 −3 M . The d,l or l forms of 2‐amino‐4‐phosphonobutyric acid (AP4), but not d‐AP4, significantly enhanced [ 3 H]IP levels to ∼135% of basal values. d,l‐AP4 and l‐AP4 also inhibited stimulation by either IBO or QUIS, but relative inhibition of QUIS effects was quantitatively less than that of IBO effects. These studies indicate that IBO represents a full agonist at these “AP4‐sensitive QUIS receptors” coupled to phosphoinositide hydrolysis in brain. QUIS is a partial agonist with the highest affinity for the receptor, and l‐AP4 represents a partial agonist with relatively weak intrinsic activity. Furthermore, this receptor effect is not mediated at “QUIS” receptor sites that are activated by AMPA.